TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -64.86%2.75M | ---- | 116.10%7.83M | ---- | -289.14%-48.65M | ---- | -75.35%25.72M | ---- | 167.36%104.36M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 17.96%-6.53M | ---- | -5.42%-7.96M | ---- | -57.70%-7.55M | ---- | ---4.79M | ---- | ---- |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 51.82%2.87M | ---- | --1.89M |
Attributable subsidiary (profit) loss | ---- | -31.03%769K | ---- | 47.49%1.12M | ---- | --756K | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -198.10%-2.48M | ---- | 141.39%2.52M | ---- | -179.97%-6.1M | ---- | 427.84%7.62M | ---- | --1.44M |
-Impairmen of inventory (reversal) | ---- | -196.30%-2.48M | ---- | 152.35%2.57M | ---- | -179.58%-4.91M | ---- | 583.92%6.17M | ---- | --902K |
-Other impairments and provisions | ---- | ---- | ---- | 96.04%-47K | ---- | -181.62%-1.19M | ---- | 168.08%1.45M | ---- | --542K |
Revaluation surplus: | ---- | -16.90%7.79M | ---- | -38.02%9.37M | ---- | 2,129.80%15.12M | ---- | ---745K | ---- | ---- |
-Other fair value changes | ---- | -16.90%7.79M | ---- | -38.02%9.37M | ---- | 2,129.80%15.12M | ---- | ---745K | ---- | ---- |
Asset sale loss (gain): | ---- | 469.91%7.5M | ---- | 166.73%1.32M | ---- | -65.16%-1.97M | ---- | 76.46%-1.19M | ---- | -180.15%-5.07M |
-Loss (gain) from sale of subsidiary company | ---- | --8.62M | ---- | ---- | ---- | ---2.38M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -184.80%-1.12M | ---- | 222.55%1.32M | ---- | 134.17%408K | ---- | 76.46%-1.19M | ---- | -180.15%-5.07M |
Depreciation and amortization: | ---- | 17.99%78.47M | ---- | 38.33%66.5M | ---- | 40.65%48.08M | ---- | -5.39%34.18M | ---- | 8.43%36.13M |
-Depreciation | ---- | 18.79%75.61M | ---- | 40.86%63.65M | ---- | 49.29%45.19M | ---- | -4.15%30.27M | ---- | 0.16%31.58M |
-Amortization of intangible assets | ---- | -6.62%395K | ---- | -3.42%423K | ---- | 5.04%438K | ---- | -45.42%417K | ---- | -57.34%764K |
Financial expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.02%-30.07M |
Special items | ---- | -70.77%627K | ---- | 98.61%2.15M | ---- | 5.16%1.08M | ---- | 107.87%1.03M | ---- | -518.84%-13.05M |
Operating profit before the change of operating capital | ---- | 7.31%88.9M | ---- | 10,757.80%82.85M | ---- | -98.82%763K | ---- | -32.35%64.7M | ---- | 107.94%95.63M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 212.79%15.65M | ---- | 324.35%5M | ---- | 96.19%-2.23M | ---- | -2,273.87%-58.56M | ---- | 1,525.40%2.69M |
Accounts receivable (increase)decrease | ---- | -91.69%3.06M | ---- | 223.67%36.82M | ---- | 13.83%-29.77M | ---- | -1,654.12%-34.55M | ---- | 135.72%2.22M |
Accounts payable increase (decrease) | ---- | -162.90%-75.75M | ---- | 52.61%120.44M | ---- | 13.14%78.92M | ---- | 234.77%69.75M | ---- | -64.37%20.84M |
Cash from business operations | 185.84%52.07M | -87.00%31.85M | -149.60%-60.66M | 414.05%245.1M | 446.45%122.29M | 15.34%47.68M | -73.85%22.38M | -65.94%41.34M | 11.59%85.56M | 23.79%121.39M |
Other taxs | -69.76%-5.77M | -13.49%-3.8M | -337.07%-3.4M | 77.77%-3.35M | 94.59%-777K | 19.25%-15.08M | -6.43%-14.37M | -133.43%-18.67M | -203.30%-13.5M | 32.80%-8M |
Interest paid - operating | 9.37%-3.9M | -257.92%-9.36M | -177.18%-4.3M | 1.28%-2.61M | -116.02%-1.55M | -1,791.43%-2.65M | ---718K | ---140K | ---- | ---- |
Net cash from operations | 162.04%42.4M | -92.18%18.69M | -156.98%-68.35M | 698.29%239.14M | 1,544.20%119.96M | 32.97%29.96M | -89.88%7.3M | -80.13%22.53M | -0.22%72.07M | 31.61%113.39M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -7.73%6.32M | 40.41%14.91M | 22.96%6.84M | -17.77%10.62M | -5.16%5.57M | -24.77%12.91M | -37.58%5.87M | 1.24%17.16M | 49.75%9.4M | 50.19%16.95M |
Decrease in deposits (increase) | -174.18%-35.81M | 194.66%10.42M | -146.27%-13.06M | -115.41%-11.01M | 141.35%28.23M | 143.64%71.47M | ---68.27M | ---163.78M | ---- | ---- |
Sale of fixed assets | -81.77%229K | 121.07%2.77M | 143.41%1.26M | -95.16%1.25M | -22.64%516K | 914.97%25.9M | -63.35%667K | -73.48%2.55M | -79.62%1.82M | 105.03%9.62M |
Purchase of fixed assets | 51.49%-51.09M | 67.10%-107.41M | 45.74%-105.31M | -6.79%-326.44M | -2.99%-194.09M | -49.73%-305.69M | -256.10%-188.44M | -62.95%-204.16M | -269.19%-52.92M | -688.46%-125.29M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.51M | ---- | ---- |
Purchase of intangible assets | ---- | -340.00%-22K | ---- | 99.08%-5K | 94.59%-4K | 95.82%-546K | 99.45%-74K | 54.04%-13.07M | 35.14%-13.42M | -17,240.85%-28.44M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --3.65M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 208.25%24.66M | ---- | --8M | 119.12%8M | ---- | --3.65M | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | 98.42%-1M | 95.59%-1M | 7.44%-63.22M | 61.00%-22.7M | -142.66%-68.3M | ---58.2M | ---28.15M |
Other items in the investment business | ---- | ---509K | ---509K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | 27.46%-80.36M | 82.68%-55.18M | 27.49%-110.79M | -24.68%-318.58M | 43.27%-152.78M | 37.99%-255.52M | -137.65%-269.3M | -165.35%-412.08M | -471.75%-113.32M | -212,632.88%-155.3M |
Net cash before financing | 78.81%-37.96M | 54.07%-36.49M | -445.81%-179.14M | 64.78%-79.45M | 87.47%-32.82M | 42.10%-225.56M | -535.17%-262M | -829.53%-389.55M | -178.71%-41.25M | -148.68%-41.91M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -46.64%121.68M | 628.69%290.02M | 106.38%228.02M | -42.98%39.8M | -12.95%110.49M | 23.04%69.8M | --126.93M | --56.73M | ---- |
Refund | 90.54%-20.43M | 41.05%-57.4M | -147.26%-216.02M | -16.85%-97.36M | -67.37%-87.36M | -46.87%-83.32M | ---52.2M | ---56.73M | ---- | ---- |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.58%148.42M | ---- | 22.20%196.79M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | --43.83M | 105.62%14.33M | ---- | ---254.74M | ---- |
Net cash from financing operations | -127.61%-20.43M | -50.80%64.28M | 255.58%74M | 81.48%130.65M | -248.98%-47.56M | -66.82%71.99M | 116.06%31.93M | 11.42%216.98M | -201.37%-198.78M | 20.93%194.74M |
Effect of rate | -100.98%-18K | 401.21%1.24M | 841.54%1.84M | 109.95%247K | 107.73%195K | 79.70%-2.48M | -129.20%-2.52M | -193.22%-12.22M | 52.55%8.64M | -46.51%13.11M |
Net Cash | 44.46%-58.39M | -45.73%27.79M | -30.79%-105.14M | 133.34%51.2M | 65.06%-80.38M | 11.01%-153.57M | 4.15%-230.08M | -212.91%-172.57M | -196.59%-240.03M | -38.15%152.84M |
Begining period cash | 6.56%471.67M | 13.15%442.64M | 13.15%442.64M | -28.52%391.19M | -28.52%391.19M | -25.24%547.24M | -25.24%547.24M | 29.32%732.03M | 29.32%732.03M | 92.25%566.09M |
Cash at the end | 21.78%413.26M | 6.56%471.67M | 9.11%339.34M | 13.15%442.64M | -1.16%311M | -28.52%391.19M | -37.15%314.64M | -25.24%547.24M | -38.96%500.64M | 29.32%732.03M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.